Ausnutria Dairy Corporation (AUDYF) Fair Value & Analysis
Consumer Defensive · US · Market cap $639M
Analysis
Ausnutria Dairy Corporation (AUDYF) currently trades at $0.3600, while our model-based Fair Value estimate is $0.3100 — implying the stock looks roughly 13.9% overvalued today. We read business quality at 94/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Ausnutria Dairy Corporation Ltd, an investment holding company, primarily engages in the research and development, production, marketing, processing, packaging, and distribution of dairy and related products, and nutrition products. It operates through the Dairy and Related Products, and Nutrition Products segments. The company offers cow and goat-based milk formula products for infants. It also engages in the marketing and distribution of goat milk nutrition products; manufacturing and distribution of cheese related products; research and development, distribution, manufacturing, and sale of probiotic products, and related fermentation-related products; and provision of financing services. The company operates in the People's Republic of China, Europe, Southeast Asia, Australia, the Middle East, North and South America, and internationally. Ausnutria Dairy Corporation Ltd was founded in 2003 and is based in Sheung Wan, Hong Kong. Ausnutria Dairy Corporation Ltd is a subsidiary of H…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.